What this guide covers
What the MHRA is
The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK's regulator for medicines, vaccines and medical devices. On the device side, it runs the UK's post-market vigilance system: it receives reports of adverse incidents, oversees manufacturers' corrective actions in the field, and publishes safety information for the NHS and the public. If you hold a UKCA mark or sell through UK distributors, what the MHRA publishes is a main surveillance source, and none of it appears in the FDA's MAUDE database.
Field safety notices (FSNs)
A field safety notice is an urgent communication a manufacturer issues to its customers and users about a field safety corrective action (FSCA), such as a recall, a modification, updated instructions or advice to stop using a device. The FSN is the manufacturer's own document. The MHRA receives it and publishes it so the wider healthcare system can see it.
So an FSN comes from the manufacturer. It's the device maker telling users "here is a problem with our product and here is what to do about it." That makes FSNs one of the most direct early signals about a device. That includes devices of the same type as yours, or from a competitor that uses the same components or a similar design.
Since 16 June 2025, new post-market surveillance rules in Great Britain mean a proposed FSN must be sent to the MHRA before it goes to customers, and it must include UDI information where available. Our guide to Great Britain's post-market surveillance rules covers the other changes, including 15-day reporting and the three working days you have to answer MHRA requests.
MHRA device alerts, and how they differ
Separately from manufacturer FSNs, the MHRA issues its own alerts when it decides more action is needed. These used to be called "Medical Device Alerts (MDAs)". Today they come in two forms:
- Device Safety Information (DSI), numbered like
DSI/2026/009, tells healthcare providers about a device risk and what to do about it. - National Patient Safety Alerts are used for the most serious risks, where providers must take specific actions by a deadline.
Both come from the regulator: the MHRA telling healthcare providers to act.
| Field Safety Notice (FSN) | MHRA device alert | |
|---|---|---|
| Issued by | The manufacturer | The MHRA (the regulator) |
| Trigger | A field safety corrective action (FSCA) | The MHRA judging further action is needed |
| Says | "Here's the issue with our device and what to do" | "Providers should take this action" |
Both appear in the MHRA's published safety information, and you should watch both. The FSN is usually the first word from the manufacturer. The MHRA alert is the regulator stepping in.
Where the MHRA publishes it
MHRA safety information is published on GOV.UK, principally under "Alerts, recalls and safety information: drugs and medical devices" (gov.uk/drug-device-alerts). You'll find Device Safety Information, National Patient Safety Alerts, recalls, the weekly Field Safety Notices lists (titled by date, for example "Field Safety Notices: 19 to 23 October 2026") and the monthly MHRA Safety Roundup. You can search it and subscribe to email updates.
Yellow Card: the reporting side
The signals the MHRA publishes start as reports in. Adverse incidents involving medical devices are reported to the MHRA through the Yellow Card scheme, the UK's system for reporting suspected problems with medicines and devices. Healthcare professionals can report device incidents directly, more and more often from inside clinical IT systems such as EMIS and SystmOne. Manufacturers report FSCAs and adverse incidents to the MHRA through its own reporting channels.
For a manufacturer, Yellow Card matters both ways. Your own vigilance reporting runs through it, and the incidents reported there are part of what later appears as published safety information about your type of device.
Why the UK is now separate from the EU
Before Brexit, UK device signals arrived bundled with EU ones. Now the UK operates its own regime, which has two consequences for monitoring:
- The MHRA is a separate source. UK FSNs and alerts no longer line up with EU vigilance data, so you have to watch both. An EU MDR post-market surveillance plan that only cites EU and FDA data has a UK-shaped gap.
- Great Britain vs Northern Ireland. Under the Windsor Framework, Northern Ireland continues to follow EU device rules while Great Britain (England, Scotland, Wales) follows the UK regime, so the UK itself is split. UKCA marking applies in GB, with CE marking accepted under transitional arrangements whose timelines have shifted more than once (always confirm the current position).
How to monitor it
A workable MHRA routine looks a lot like the MAUDE workflow, adapted for a source with no dedicated device API:
- Subscribe to the GOV.UK drug-device-alerts updates and monitor the weekly FSN listings.
- Scope by your brand and manufacturer names and your device category. FSNs from other makers of the same type of device can warn you early about risks you share.
- Triage each hit: is it your device, a competitor's, or a component you rely on?
- Log findings into your PMS system with the source and date, so your UK coverage is evidenced, not assumed.
Any one source is manageable. The difficulty is doing this for the UK, the US, Canada, Switzerland and the EU at the same time, each with its own format, schedule and way of accessing it, and then removing duplicates and matching everything to your devices. Done by hand, it's the first job that slips when the team gets busy.
The MHRA is one source of many
MedFortis consolidates MHRA safety information alongside openFDA, Health Canada, Swissmedic, EUDAMED and other national sources in one device lookup, matched to your device lines and logged. Book a demo to see it on your own devices.
Book a Demo →Key takeaways
- The MHRA is the UK's medical device regulator. FDA data doesn't cover what it publishes, and since Brexit it has run its own system.
- FSNs are manufacturer-issued (a field safety corrective action); MHRA device alerts are regulator-issued escalations. Watch both.
- It's all on GOV.UK (
gov.uk/drug-device-alerts), searchable and subscribable, with no dedicated device-alert API (GOV.UK's general search and content APIs can be used). - Incidents reach the MHRA via the Yellow Card scheme; the GB/Northern Ireland split means the UK picture itself is divided.
- Search by device category as well as your own brand. Competitors' FSNs can warn you early about risks you share.